3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with technetium tc 99m exametazime in 8 studies
| Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (technetium tc 99m exametazime) | Trials (technetium tc 99m exametazime) | Recent Studies (post-2010) (technetium tc 99m exametazime) |
|---|---|---|---|---|---|
| 330 | 40 | 33 | 2,986 | 259 | 198 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coppola, R; Gorey, J; Hyde, TM; Jones, DW; Knable, MB; Lee, KS; Weinberger, DR | 1 |
| Bartenstein, P; Lerch, H; Masur, H; Oberwittler, C; Saur, HB; Schober, O | 1 |
| Hagspiel, KD; Hermes, M; Kujat, C; Neidl, KF; Voges, M | 1 |
| Ballinger, JR; Fornazzari, L; Ichise, M; Kirsh, JC; Toyama, H | 1 |
| Battistin, L; Borsato, N; Briani, C; Chierichetti, F; Dam, M; Ferlin, G; Pizzolato, G; Rossato, A; Saitta, B; Zanco, P | 1 |
| Aurengo, A; El Fakhri, G; Kijewski, MF; Maksud, P; Moore, SC | 1 |
| Leenders, KL | 1 |
| Oros-Peusquens, AM; Pissarek, MB; Schramm, NU | 1 |
2 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and technetium tc 99m exametazime
| Article | Year |
|---|---|
[Single photon emission tomography (SPECT). Cerebral function diagnosis for the clinical routine. Indications and radiotracers].
Topics: Benzamides; Brain Diseases; Flumazenil; Humans; Iodine Radioisotopes; Organotechnetium Compounds; Oximes; Pyrrolidines; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Significance of non-presynaptic SPECT tracer methods in Parkinson's disease.
Topics: Benzamides; Brain; Corpus Striatum; Diagnosis, Differential; Humans; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Receptors, Presynaptic; Regional Blood Flow; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and technetium tc 99m exametazime
| Article | Year |
|---|---|
[Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Benzamides; Brain; Cerebellum; Cerebrovascular Circulation; Dopamine Antagonists; Frontal Lobe; Humans; Huntington Disease; Iodine Radioisotopes; Middle Aged; Organotechnetium Compounds; Oximes; Parkinson Disease; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1994 |
5 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and technetium tc 99m exametazime
| Article | Year |
|---|---|
Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
Topics: Adult; Aged; Basal Ganglia; Benzamides; Cerebrovascular Circulation; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Organotechnetium Compounds; Oximes; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1995 |
Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Topics: Adolescent; Adult; Aged; Benzamides; Brain; Cerebrovascular Circulation; Female; Humans; Huntington Disease; Male; Middle Aged; Organotechnetium Compounds; Oximes; Pyrrolidines; Receptors, Dopamine D2; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Dopamine receptor SPET imaging in Parkinson's disease: a [123I]-IBZM and [99mTc]-HM-PAO study.
Topics: Adult; Aged; Basal Ganglia; Benzamides; Female; Humans; Levodopa; Male; Middle Aged; Organotechnetium Compounds; Oximes; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT.
Topics: Alzheimer Disease; Benzamides; Brain; Cerebellum; Cerebral Cortex; Cerebrovascular Circulation; Corpus Callosum; Humans; Iodine Radioisotopes; Monte Carlo Method; Neural Networks, Computer; Parkinson Disease; Phantoms, Imaging; Putamen; Pyrrolidines; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2001 |
Challenge by the murine brain: multi-pinhole SPECT of 123I-labelled pharmaceuticals.
Topics: Anesthesia; Animals; Benzamides; Brain; Iodine Radioisotopes; Magnetic Resonance Imaging; Mice; Organotechnetium Compounds; Pyrrolidines; Radiopharmaceuticals; Rats; Rats, Inbred WKY; Reference Standards; Technetium Tc 99m Exametazime; Thyroid Gland; Tomography, Emission-Computed, Single-Photon; Tropanes | 2008 |